Hyperglycemia suppresses ABCA1 expression in vascular smooth muscle cells

Hormone and Metabolic Research

Volumn 42, Issue 4, 2010, Pages 241-246

  Yu, X ^a,b   Murao, K ^a   Imachi, H ^a   Li, J ^a   Nishiuchi, T ^a   Hosomi, N ^a   Masugata, H ^a   Zhang, G X ^c   Iwama, H ^d   Ishida, T ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b SOOCHOW UNIVERSITY   (China)

^c NARA MEDICAL UNIVERSITY   (Japan)

^d KAGAWA UNIVERSITY   (Japan)

Author keywords

ABCA1; Diabetes; HDL; Hyperglycemia; Smooth muscle cells

Indexed keywords

ABC TRANSPORTER A1; GLUCOSE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; HYPERGLYCEMIA; IMIDAZOLES; MAP KINASE SIGNALING SYSTEM; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS, GENETIC; PYRIDINES; TRANSCRIPTION, GENETIC;

EID: 77950496496     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1246183     Document Type: Article

References (17)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979 241 2035-2038
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993 16 434-444
3. Pugliese G, Tilton RG, Williamson JR. Glucose-induced metabolic imbalances in the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 1991 7 35-59
4. Tall AR. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest 1990 86 379-384
5. Tall AR, Wang N. Tangier disease as a test of the reverse cholesterol transport hypothesis. J Clin Invest 2000 106 1205-1207
6. Murao K, Yu X, Imachi H, Cao WM, Chen K, Matsumoto K, Nishiuchi T, Wong NC, Ishida T. Hyperglycemia suppresses hepatic scavenger receptor class B type I expression. Am J Physiol Endocrinol Metab 2008 294 E78-E87
7. Nagao S, Murao K, Imachi H, Cao WM, Yu X, Li J, Matsumoto K, Nishiuchi T, Ahmed RA, Wong NC, Ueda K, Ishida T. Platelet derived growth factor regulates ABCA1 expression in vascular smooth muscle cells. FEBS Lett 2006 580 4371-4376
8. Yu X, Murao K, Imachi H, Cao WM, Li L, Matsumoto K, Nishiuchi T, Ahmed RA, Wong NC, Kosaka H, Unterman TG, Ishida T. Regulation of scavenger receptor class BI gene expression by angiotensin II in vascular endothelial cells. Hypertension 2007 49 1378-1384
9. Langmann T, Porsch-Ozcurumez M, Heimerl S, Probst M, Moehle C, Taher M, Borsukova H, Kielar D, Kaminski WE, Dittrich-Wengenroth E, Schmitz G. Identification of sterol-independent regulatory elements in the human ATP-binding cassette transporter A1 promoter: role of Sp1/3, E-box binding factors, and an oncostatin M-responsive element. J Biol Chem 2002 27 14443-14450
10. Imachi H, Murao K, Cao W, Tada S, Taminato T, Wong NC, Takahara J, Ishida T. Expression of human scavenger receptor B1 on and in human platelets. Arterioscler Thromb Vasc Biol 2003 23 898-904
11. Begum N, Ragolia L. High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation. Am J Physio 2000 l278 C81-C91
12. Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang ZY, Yamauchi T, Kuboki K, Meier M, Rhodes CJ, King GL. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 1999 103 185-195
13. Serfaty-Lacrosniere C, Civeira F, Lanzberg A, Isaia P, Berg J, Janus ED, Smith MP, Pritchard PH, Frohlich J, Lees RS. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis 1994 107 85-98
14. Ruderman NB, Williamson JR, Brownlee M. Glucose and diabetic vascular disease. FASEB J 1992 6 2905-2914
15. Haffner SM. Risk constellations in patients with the metabolic syndrome: Epidemiology, diagnosis, and treatment patterns. Am J Med 2006 119 S3-S9
16. Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Diabetes Care 2003 26 810-818
17. Sampson MJ, Davies IR, Braschi S, Ivory K, Hughes DA. Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes. Atherosclerosis 2003 167 129-134